Skip to main content

Table 1 Descriptive characteristics CF patients by screening status

From: Impact of newborn screening for cystic fibrosis on clinical outcomes of pediatric patients: 10 years’ experience in Lodz Voivodship

Investigated trait Statistical parameters
Screened
Group CF NBS (n = 27)
Unscreened
Group CF (n = 52)
Sex, n (%)
Females 16 (59.26) 24 (46.15)
Males 11 (40.74) 28 (53.85)
Birth weight (g),
mean (SD), min.-max. 3168.52 (715.10), 970–4220 3195.60 (526.03), 2330–4400
median (Q1-Q3), min.-max. 3310 (2800–3620), 970–4400 3190 (2800–3600), 2330–4400
APGAR rating,
mean (SD), min.-max. 8.78 (1.69), 3–10 8.54 (1.88), 1–10
median (Q1-Q3), min.-max. 9 (8–10), 3–10 9 (9–9), 1–10
F508del mutation, n (%)
overall 24 (88.89) 46 (88.46)
in both alleles 8 (29.63) 26 (50.00)
Meconium ileus, n (%) 9 (33.33) 9 (17.31)
Concentration of chlorides (mmol/l),
mean (SD), min.-max. 98.93 (25.14), 10–123 100.83 (20.36), 60–152
median (Q1-Q3), min.-max. 106 (89.117), 10–123 100 (90–110), 60–152
  1. (Abbreviations: n number; SD standard deviation; Q1 lower quartile; Q3 upper quartile; min minimum value; max. maximum value)